SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-22-014409
Filing Date
2022-09-14
Accepted
2022-09-14 17:30:53
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 tmb-20220912xs3.htm S-3 293037
2 EX-5.1 tmb-20220912xex5d1.htm EX-5.1 11390
3 EX-23.1 tmb-20220912xex23d1.htm EX-23.1 2503
4 EX-23.2 tmb-20220912xex23d2.htm EX-23.2 3189
5 EX-FILING FEES tmb-20220912xexfilingfees.htm EX-FILING FEES 26325
6 GRAPHIC tmb-20220912xs3013.jpg GRAPHIC 10879
7 GRAPHIC tmb-20220912xs3008.jpg GRAPHIC 10855
8 GRAPHIC tmb-20220912xex5d1005.jpg GRAPHIC 6060
9 GRAPHIC tmb-20220912xex5d1002.jpg GRAPHIC 9240
10 GRAPHIC tmb-20220912xex5d1006.jpg GRAPHIC 6825
11 GRAPHIC tmb-20220912xex5d1007.jpg GRAPHIC 2253
  Complete submission text file 0001558370-22-014409.txt   402018
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: S-3 | Act: 33 | File No.: 333-267426 | Film No.: 221243831
SIC: 2834 Pharmaceutical Preparations